S-Plexes and Diluents - Kits
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of the Navy, Naval Medical Research Command (NMRC), intends to award a sole-source contract to Meso Scale Discovery (MSD) in Rockville, MD, for S-Plexes and Diluents kits. This acquisition is for brand name equipment required for biomarker detection. While not a request for competitive proposals, interested parties may submit capability statements for consideration.
Scope of Work
NMRC's Infectious Diseases/CWID Director requires specific assay kits and associated diluents/buffers to detect low-level biomarkers in various tissue samples. The kits must be compatible with the existing MESO QuickPlex SQ 120MM detection platform. The required items include various S-PLEX Human kits (e.g., TNF-β, IL-1β, Neurofilament L, GFAP, Tau (pT217), IL-6, TNF-α, GM-CSF, IL-10), S-PLEX Proinflammatory Panel 1, S-PLEX Neurology Panel 1, and specific diluents (Diluent 40, Diluent 42, MSD Tris Lysis Buffer).
Contract & Timeline
- Type: Special Notice (Intent to Sole Source)
- Set-Aside: Other Than Full and Open Competition (Sole Source to Meso Scale Discovery)
- NAICS: 325413 (In-Vitro Diagnostic Substance Manufacturing)
- PSC: 6640 (Laboratory Equipment And Supplies)
- Response Due: May 14, 2026, 4:00 PM ET
- Published: May 4, 2026
- Authority: 10 U.S.C. 2304(c)(1) and FAR 6.302-1
Justification
The acquisition is justified as a sole-source procurement because Meso Scale Discovery is the original manufacturer with proprietary techniques. They are identified as the only company capable of providing kits with the required sensitivity level for the existing MESO QuickPlex SQ 120MM platform, which is essential for measuring neurotrauma biomarkers. Market research indicated no other suitable sources.
Action Items
Interested vendors who believe they can meet this requirement may submit capability statements for the Government's consideration. All contractors must be registered in the System for Award Management (SAM.gov) to be eligible for an award.